Highly sensitive immunoassay of free prostate-specific antigen in serum using europium(III) nanoparticle label technology (Q78861495)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559598%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

title

Highly sensitive immunoassay of free prostate-specific antigen in serum using europium(III) nanoparticle label technology (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559598%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

1 reference

Tero Soukka

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559598%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

Katri Antonen

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559598%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

Harri Härmä

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559598%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

Anne-Maria Pelkkikangas

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559598%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

Petri Huhtinen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559598%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

Timo Lövgren

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559598%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

publication date

1 February 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559598%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559598%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

volume

328

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559598%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559598%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

page(s)

45-58

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559598%20AND%20SRC:MED&resulttype=core&format=json

Prostate-specific antigen, its molecular forms, and other kallikrein markers for detection of prostate cancer

17 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900376-5

Use of the complex between prostate specific antigen and alpha 1-protease inhibitor for screening prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900376-5

Determination of prostate-specific antigen complexed to alpha(2)-macroglobulin in serum increases the specificity of free to total PSA for prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900376-5

Prostate-specific antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900376-5

Clinical value of human glandular kallikrein 2 and free and total prostate-specific antigen in serum from a population of men with prostate-specific antigen levels 3.0 ng/mL or greater

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900376-5

Time-resolved detection of lanthanide luminescence for ultrasensitive bioanalytical assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900376-5

Development of highly fluorescent detection reagents for the construction of ultrasensitive immunoassays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900376-5

Zeptomole detection sensitivity of prostate-specific antigen in a rapid microtitre plate assay using time-resolved fluorescence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900376-5

Utilization of kinetically enhanced monovalent binding affinity by immunoassays based on multivalent nanoparticle-antibody bioconjugates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900376-5

Production of recombinant PSA and HK2 and analysis of their immunologic cross-reactivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900376-5

Determination and analysis of antigenic epitopes of prostate specific antigen (PSA) and human glandular kallikrein 2 (hK2) using synthetic peptides and computer modeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900376-5

Luminescent oxygen channeling immunoassay: measurement of particle binding kinetics by chemiluminescence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900376-5

Detection of cell and tissue surface antigens using up-converting phosphors: a new reporter technology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900376-5

Europium as a label in time-resolved immunofluorometric assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900376-5

Enzyme-amplified lanthanide luminescence for enzyme detection in bioanalytical assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900376-5

In vitro stability of free prostate-specific antigen (PSA) and prostate-specific antigen (PSA) complexed to alpha 1-antichymotrypsin in blood samples

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900376-5

Time-resolved fluorometry (TRF)-based immunoassay concept for rapid and quantitative determination of biochemical myocardial infarction markers from whole blood, serum and plasma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900376-5

Relapse and cure rates of prostate cancer patients after radical prostatectomy and 5 years of follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900376-5

Comparison of the percent free prostate-specific antigen levels in the serum of healthy men and in men with recurrent prostate cancer after radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2802%2900376-5

10.1016/S0009-8981(02)00376-5

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559598%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

1 reference